| 1. |
Guglielmi A, Ruzzenente A, Conci S, et al. How much remnant is enough in liver resection? Dig Surg, 2012, 29(1): 6-17.
|
| 2. |
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg, 2012, 255(3): 405-414.
|
| 3. |
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017 年版). 中华消化外科杂志, 2017, 16 (7): 635-647.
|
| 4. |
van Lienden KP, van den Esschert JW, de Graaf W, et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol, 2013, 36(1): 25-34.
|
| 5. |
Pandanaboyana S, Bell R, Hidalgo E, et al. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery, 2015, 157(4): 690-698.
|
| 6. |
Schlegel A, Lesurtel M, Melloul E, et al. ALPPS: from human to mice highlighting accelerated and novel mechanisms of liver regeneration. Ann Surg, 2014, 260(5): 839-847.
|
| 7. |
Schadde E, Malagó M, Hernandez-Alejandro R, et al. Monosegment ALPPS hepatectomy: extending resectability by rapid hypertrophy. Surgery, 2015, 157(4): 676-689.
|
| 8. |
Eshmuminov D, Tschuor C, Raptis DA, et al. Rapid liver volume increase induced by associating liver partition with portal vein ligation for staged hepatectomy (ALPPS): Is it edema, steatosis, or true proliferation? Surgery, 2017, 161(6): 1549-1552.
|
| 9. |
Line PD, Hagness M, Berstad AE, et al. A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: The RAPID Concept. Ann Surg, 2015, 262(1): e5-e9.
|
| 10. |
Schadde E, Raptis DA, Schnitzbauer AA, et al. Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the International ALPPS Registry. Ann Surg, 2015, 262(5): 780-786.
|
| 11. |
Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry. Ann Surg, 2014, 260(5): 829-838.
|
| 12. |
Olthof PB, Tomassini F, Huespe PE, et al. Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function. Surgery, 2017, 162(4): 775-783.
|
| 13. |
Tanaka K, Matsuo K, Murakami T, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity. Eur J Surg Oncol, 2015, 41(4): 506-512.
|
| 14. |
Serenari M, Collaud C, Alvarez FA, et al. Interstage assessment of remnant liver function in ALPPS using hepatobiliary scintigraphy: Prediction of posthepatectomy liver failure and introduction of the HIBA index. Ann Surg, 2017 Jan 24. doi: 10.1097/SLA.0000000000002150. [Epub ahead of print].
|
| 15. |
Cieslak KP, Huisman F, Bais T, et al. Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization. Surgery, 2017, 162(1): 37-47.
|
| 16. |
黄拼搏, 胡志刚, 许侨东, 等. ALPPS 在具有乙肝肝硬化背景的巨块型肝癌中的应用. 岭南现代临床外科, 2015, 15(5): 527-532.
|
| 17. |
Wiederkehr JC, Avilla SG, Mattos E, et al. Associating liver partition with portal vein ligation and staged hepatectomy (ALPPS) for the treatment of liver tumors in children. J Pediatr Surg, 2015, 50(7): 1227-1231.
|
| 18. |
Truant S, Scatton O, Dokmak S, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management. Eur J Surg Oncol, 2015, 41(5): 674-682.
|
| 19. |
Robles-Campos R, Brusadin R, López-Conesa A, et al. Modified ALPPS procedures avoiding division of portal pedicles. Ann Surg, 2017, 265(2): e21.
|
| 20. |
Tanaka K, Kikuchi Y, Kawaguchi D, et al. Modified ALPPS procedures avoiding division of portal pedicles. Ann Surg, 2017, 265(2): e14-e20.
|
| 21. |
Alvarez FA, Ardiles V, de Santibañes M, et al. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg, 2015, 261(4): 723-732.
|
| 22. |
Linecker M, Stavrou GA, Oldhafer KJ, et al. The ALPPS risk score: avoiding futile use of ALPPS. Ann Surg, 2016, 264(5): 763-771.
|
| 23. |
Bertens KA, Hawel J, Lung K, et al. ALPPS: challenging the concept of unresectability—a systematic review. Int J Surg, 2015, 13: 280-287.
|
| 24. |
Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology, 2001, 34(2): 267-272.
|
| 25. |
Oldhafer KJ, Donati M, Jenner RM, et al. ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence. World J Surg, 2014, 38(6): 1504-1509.
|
| 26. |
Vennarecci G, Laurenzi A, Levi Sandri GB, et al. The ALPPS procedure for hepatocellular carcinoma. Eur J Surg Oncol, 2014, 40(8): 982-988.
|
1/5
WeChat